14485

530199

THEMISMED

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

THEMIS MEDICARE LTD. Share Price Today

THEMIS MEDICARE LTD. is currently trading at ₹114.33, down by ₹3.86 from the previous close. The stock touched an intraday high of ₹119.59 and a low of ₹113.21 during the latest trading session. Over the past one year, THEMIS MEDICARE LTD. has delivered a loss of 13.67%, while the stock has gained 14.05% in the last one month.

THEMIS MEDICARE LTD. performance

Today’s low Today’s high
₹ 113.21 ₹ 119.59
₹ 114.33
52 week low 52 week high
₹ 64.95 ₹ 148.00
₹ 114.33
Open Price ₹ 118.00
Prev. Close ₹ 118.20
Volume (Shares) 179662.00
Total traded value ₹ 205.40
Upper Circuit ₹ 141.84
Lower Circuit ₹ 94.56
info

Investment Returns

Over 1 Month 14.05% Over 3 Months 52.31% Over 6 Months 12.57% Over 1 Year -13.67%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

THEMIS MEDICARE LTD. fundamentals


  • Market cap (Cr) 1,053.00
  • P/E Ratio (TTM) -74.03
  • Beta 1.40
  • Book Value / share 29.09
  • Return on equity 8.62%
  • EPS (TTM) 0.00
  • Dividend yield 0.44%
  • Net profit/quarter (Cr) 1.97
info icon alternate text
  • Market cap (Cr) 1,049.90
  • P/E Ratio (TTM) -74.03
  • Beta 1.24
  • Book Value / share 29.09
  • Return on equity 8.62%
  • EPS (TTM) 0.00
  • Dividend yield 0.44%
  • Net profit/quarter (Cr) 1.97
info icon alternate text

THEMIS MEDICARE LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 76.53
Operating Expense 78.06
Net Profit 1.97
Net Profit Margin (%) 2.57
Earnings Per Share (EPS) 0.21
EBITDA 7.43
Effective Tax Rate (%) 7.94
Particulars DEC 2025 (Values in Cr)
Revenue 90.13
Operating Expense 85.68
Net Profit 4.58
Net Profit Margin (%) 5.08
Earnings Per Share (EPS) 0.50
EBITDA 10.21
Effective Tax Rate (%) 5.95
Particulars SEP 2025 (Values in Cr)
Revenue 77.99
Operating Expense 86.42
Net Profit -5.36
Net Profit Margin (%) -6.87
Earnings Per Share (EPS) -0.58
EBITDA 0.13
Effective Tax Rate (%) -3.08
Particulars JUN 2025 (Values in Cr)
Revenue 97.58
Operating Expense 112.67
Net Profit -15.37
Net Profit Margin (%) -15.75
Earnings Per Share (EPS) -1.67
EBITDA -10.20
Effective Tax Rate (%) -1.05
Particulars MAR 2025 (Values in Cr)
Revenue 71.70
Operating Expense 82.46
Net Profit -7.74
Net Profit Margin (%) -10.79
Earnings Per Share (EPS) -0.84
EBITDA -4.23
Effective Tax Rate (%) 15.85
Particulars MAR 2026 (Values in Cr)
Revenue 342.24
Operating Expense 362.84
Net Profit -14.19
Net Profit Margin (%) -4.14
Earnings Per Share (EPS) -1.54
EBITDA 7.60
Effective Tax Rate (%) -5.82
Particulars MAR 2025 (Values in Cr)
Revenue 405.51
Operating Expense 376.42
Net Profit 23.92
Net Profit Margin (%) 5.89
Earnings Per Share (EPS) 2.60
EBITDA 53.73
Effective Tax Rate (%) 29.14
Particulars MAR 2024 (Values in Cr)
Revenue 381.76
Operating Expense 351.85
Net Profit 24.75
Net Profit Margin (%) 6.48
Earnings Per Share (EPS) 2.69
EBITDA 56.30
Effective Tax Rate (%) 28.61
Particulars MAR 2023 (Values in Cr)
Revenue 354.32
Operating Expense 306.92
Net Profit 43.29
Net Profit Margin (%) 12.21
Earnings Per Share (EPS) 47.05
EBITDA 78.96
Effective Tax Rate (%) 26.49
Particulars MAR 2022 (Values in Cr)
Revenue 394.61
Operating Expense 317.21
Net Profit 61.56
Net Profit Margin (%) 15.60
Earnings Per Share (EPS) 66.91
EBITDA 102.19
Effective Tax Rate (%) 26.66
Particulars MAR 2025 (Values in Cr)
Book Value / Share 40.16
ROE % 8.36
ROCE % 11.09
Total Debt to Total Equity 0.25
EBITDA Margin 14.71
Particulars MAR 2024 (Values in Cr)
Book Value / Share 37.41
ROE % 13.39
ROCE % 14.99
Total Debt to Total Equity 0.29
EBITDA Margin 19.66
Particulars MAR 2023 (Values in Cr)
Book Value / Share 332.15
ROE % 20.36
ROCE % 22.45
Total Debt to Total Equity 0.31
EBITDA Margin 26.13
Particulars MAR 2022 (Values in Cr)
Book Value / Share 275.34
ROE % 33.33
ROCE % 34.44
Total Debt to Total Equity 0.38
EBITDA Margin 28.77
Particulars MAR 2021 (Values in Cr)
Book Value / Share 200.18
ROE % 21.51
ROCE % 20.82
Total Debt to Total Equity 0.56
EBITDA Margin 27.13
Particulars MAR 2025 (Values in Cr)
Book Value / Share 31.22
ROE % 8.62
ROCE % 11.88
Total Debt to Total Equity 0.32
EBITDA Margin 13.25
Particulars MAR 2024 (Values in Cr)
Book Value / Share 29.11
ROE % 9.59
ROCE % 12.48
Total Debt to Total Equity 0.36
EBITDA Margin 14.74
Particulars MAR 2023 (Values in Cr)
Book Value / Share 269.54
ROE % 18.93
ROCE % 21.75
Total Debt to Total Equity 0.38
EBITDA Margin 22.28
Particulars MAR 2022 (Values in Cr)
Book Value / Share 227.50
ROE % 34.15
ROCE % 35.15
Total Debt to Total Equity 0.46
EBITDA Margin 25.90
Particulars MAR 2021 (Values in Cr)
Book Value / Share 164.59
ROE % 19.32
ROCE % 19.43
Total Debt to Total Equity 0.68
EBITDA Margin 23.19
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 12.83
Total Assets 588.03
Total Liabilities 588.03
Total Equity 402.59
Share Outstanding 9
Price to Book Ratio 4.70
Return on Assets (%) 5.07
Return on Capital (%) 6.14
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 0.00
Total Liabilities 0.00
Total Equity 0.00
Share Outstanding 0
Price to Book Ratio 7.52
Return on Assets (%) 0.00
Return on Capital (%) 0
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 0.00
Total Liabilities 0.00
Total Equity 0.00
Share Outstanding 0
Price to Book Ratio 4.33
Return on Assets (%) 0.00
Return on Capital (%) 0
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 26.49
Total Assets 427.78
Total Liabilities 427.78
Total Equity 287.48
Share Outstanding 0
Price to Book Ratio 4.10
Return on Assets (%) 17.03
Return on Capital (%) 19.91
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 24.63
Total Assets 371.14
Total Liabilities 371.14
Total Equity 218.50
Share Outstanding 0
Price to Book Ratio 1.70
Return on Assets (%) 9.61
Return on Capital (%) 11.76
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 12.74
Total Assets 505.65
Total Liabilities 505.65
Total Equity 320.28
Share Outstanding 9
Price to Book Ratio 4.70
Return on Assets (%) 4.73
Return on Capital (%) 5.93
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 19.20
Total Assets 489.96
Total Liabilities 489.96
Total Equity 301.27
Share Outstanding 9
Price to Book Ratio 7.52
Return on Assets (%) 5.05
Return on Capital (%) 6.23
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 18.85
Total Assets 456.28
Total Liabilities 456.28
Total Equity 281.82
Share Outstanding 0
Price to Book Ratio 4.33
Return on Assets (%) 9.48
Return on Capital (%) 11.58
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 26.48
Total Assets 383.73
Total Liabilities 383.73
Total Equity 243.48
Share Outstanding 0
Price to Book Ratio 4.10
Return on Assets (%) 16.04
Return on Capital (%) 19.12
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 24.62
Total Assets 338.40
Total Liabilities 338.40
Total Equity 185.80
Share Outstanding 0
Price to Book Ratio 1.70
Return on Assets (%) 7.86
Return on Capital (%) 9.82
Particulars MAR 2025 (Values in Cr)
Net Income 39.67
Cash from Operations 45.46
Cash from Investing -12.17
Cash from Financing -25.89
Net change in Cash -3.36
Free Cash Flow 60.88
Particulars MAR 2024 (Values in Cr)
Net Income 53.44
Cash from Operations 31.04
Cash from Investing -15.94
Cash from Financing -8.77
Net change in Cash -2.62
Free Cash Flow 49.46
Particulars MAR 2023 (Values in Cr)
Net Income 72.51
Cash from Operations 32.24
Cash from Investing -23.96
Cash from Financing 0.13
Net change in Cash -7.73
Free Cash Flow 60.99
Particulars MAR 2022 (Values in Cr)
Net Income 95.26
Cash from Operations 52.46
Cash from Investing -15.58
Cash from Financing -17.54
Net change in Cash 1.26
Free Cash Flow 73.09
Particulars MAR 2021 (Values in Cr)
Net Income 41.33
Cash from Operations 56.89
Cash from Investing -15.65
Cash from Financing -25.64
Net change in Cash 15.67
Free Cash Flow 74.93
Particulars MAR 2025 (Values in Cr)
Net Income 33.76
Cash from Operations 45.45
Cash from Investing -12.17
Cash from Financing -25.89
Net change in Cash -3.36
Free Cash Flow 60.88
Particulars MAR 2024 (Values in Cr)
Net Income 34.66
Cash from Operations 31.00
Cash from Investing -15.95
Cash from Financing -8.77
Net change in Cash -2.68
Free Cash Flow 49.41
Particulars MAR 2023 (Values in Cr)
Net Income 58.90
Cash from Operations 32.22
Cash from Investing -23.96
Cash from Financing 0.13
Net change in Cash -7.75
Free Cash Flow 60.97
Particulars MAR 2022 (Values in Cr)
Net Income 83.93
Cash from Operations 52.46
Cash from Investing -15.58
Cash from Financing -17.54
Net change in Cash 1.26
Free Cash Flow 73.09
Particulars MAR 2021 (Values in Cr)
Net Income 32.24
Cash from Operations 56.89
Cash from Investing -15.65
Cash from Financing -25.64
Net change in Cash 15.67
Free Cash Flow 74.93
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.51 13.02 1.52 241.47 23.12 38.85
BLISS GVS PHARMA LTD 492.50 39.98 4.37 5223.27 118.35 495.00
CIPLA LTD. 1440.30 30.57 3.37 116353.96 1165.55 1672.20
FERMENTA BIOTECH LTD. 365.50 16.12 2.64 1075.70 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.51 22.03 4.05 241.47 23.12 38.85
AMRUTANJAN HEALTH CARE LTD. 538.05 24.12 4.20 1555.54 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8382.65 109.48 24.01 20956.63 7630.00 9850.00
BLISS GVS PHARMA LTD 492.50 53.13 4.52 5223.27 118.35 495.00

THEMIS MEDICARE LTD. shareholding pattern

Holding
32.77%
67.1%
0.1%
0.01%
2.43%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

THEMIS MEDICARE LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
114.33 -3.27 redarrow
red-green-graph indicator
1 Bearish
15 Bullish
  • 5 Days 114.10
  • 26 Days 106.10
  • 10 Days 110.90
  • 50 Days 101.50
  • 12 Days 110.00
  • 100 Days 98.40
  • 20 Days 107.60
  • 200 Days 107.20
118.52 PIVOT
First Support 116.45 First Resistance 120.27 Second Support 114.70 Second Resistance 122.34 Third Support 112.63 Third Resistance 124.09
RSI 60.20 ADX 42.86 MACD 3.91 Williams % R -61.27 Commodity Channel Index (CCI) 117.05
Date 2026-06-25 Week 208734.00 Same Day 70161.00 Month 89721.00
1 Year 1.40 3 Year 1.52
Over 1 Month
14.05% down
Over 1 Year
-13.67% down
Over 3 Months
52.31% down
Over 3 Years
-6.22% down
Over 6 Months
12.57% down
Over 5 Years
10.08% down

THEMIS MEDICARE LTD. Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
04 Sep 2025 0.5 Final 05 Sep 2025 Equity shares
12 Jul 2024 0.5 Final 15 Jul 2024 Equity shares
01 Sep 2023 5.0 Final 02 Sep 2023 Equity shares
08 Sep 2022 5.0 Final 12 Sep 2022 Equity shares
08 Sep 2021 4.3 Final 11 Sep 2021 Equity shares
17 Sep 2020 1.75 Final 21 Sep 2020 Equity shares
20 Jul 2011 3.0 Final 22 Jul 2011 Equity shares
16 Jun 2010 3.0 Final 18 Jun 2010 Equity shares
01 Aug 2008 2.5 Final 05 Aug 2008 Equity shares
14 Sep 2007 2.0 Final 18 Sep 2007 Equity shares
03 Aug 2005 0.0 Final 05 Aug 2005 Equity shares
Ex-Date Old FV NEW FV Record Date
10 Oct 2023 10.0 1.0 10 Oct 2023
Dividend date Dividend amount Dividend type Record date Instrument type
04 Sep 2025 0.5 Final 05 Sep 2025 Equity shares
12 Jul 2024 0.5 Final 15 Jul 2024 Equity shares
01 Sep 2023 5.0 Final 02 Sep 2023 Equity shares
08 Sep 2022 5.0 Final 12 Sep 2022 Equity shares
08 Sep 2021 4.3 Final 11 Sep 2021 Equity shares
17 Sep 2020 1.75 Final 21 Sep 2020 Equity shares
20 Jul 2011 3.0 Final 22 Jul 2011 Equity shares
16 Jun 2010 3.0 Final 18 Jun 2010 Equity shares
01 Aug 2008 2.5 Final 05 Aug 2008 Equity shares
14 Sep 2007 2.0 Final 18 Sep 2007 Equity shares
03 Aug 2005 0.0 Final 05 Aug 2005 Equity shares
Ex-Date Old FV NEW FV Record Date
10 Oct 2023 10.0 1.0 10 Oct 2023

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Themis Medicare Ltd?

Answer Field

Themis Medicare Ltd share price is for NSE ₹ 114.33 & for BSE ₹ 114.00 as on Jun 25 2026 03:30 PM.

What is the Market Cap of Themis Medicare Ltd Share?

Answer Field

The market cap of Themis Medicare Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 25 2026 03:30 PM.

What is the 52 Week High and Low of Themis Medicare Ltd?

Answer Field

The 52 Week High and Low of Themis Medicare Ltd for NSE is ₹ 148.00 and ₹ 64.95 and for BSE is ₹ 147.99 and ₹ 65.00.

What is 1 year return for Themis Medicare Ltd?

Answer Field

The 1 year returns on the stock has been -13.67%.

What is the P/E Ratio of Themis Medicare Ltd Share?

Answer Field

As on Jun 25 2026 03:30 PM the price-to-earnings (PE) ratio for Themis Medicare Ltd share is -74.03.

What is the PB ratio of Themis Medicare Ltd Share?

Answer Field

As on Jun 25 2026 03:30 PM, the price-to-book (PB) ratio for Themis Medicare Ltd share is 29.09.

How to Buy Themis Medicare Ltd Share?

Answer Field

You can trade in Themis Medicare Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Themis Medicare Ltd Share on Bajaj Broking App?

Answer Field

To buy Themis Medicare Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Themis Medicare Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|